Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.08 USD
−8.08 M USD
83.52 M USD
19.10 M
About THERATECHNOLOGIES INC
Sector
Industry
CEO
Paul Lévesque
Website
Headquarters
Montréal
Founded
1993
FIGI
BBG000BT60N1
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
No news here
Looks like there's nothing to report right now
$THTX is gonna fall todayPupm&Dump trading strategy idea.
$THTX is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $3.90;
stop-loss — $4.60;
take-profit — $2.50;
Do not view th
SORT1+ Technology is Effective in Many Treatment-Resistant CanceNew Data Show Theratechnologies’ SORT1+ Technology is Effective in Many Treatment-Resistant Cancers
Peptide-drug conjugates TH1902 and TH1904 show significant reduction in the formation of vasculogenic mimicry by targeting the sortilin receptor
Curcumin shows increased anticancer activity when con
Round 2? Similar Breakout Pattern $THWe are seeing a very similar pattern to the one we saw just a month ago. Increased volume on the break, 20 RSI remaining bullish above the 50 line and crossing above the 10MA, MACD moving toward bullish crossover. 200MA and 100MA moving up steadily, short term GMMA consolidating with price and now t
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of THTX is 2.70 USD — it has increased by 7.06% in the past 24 hours. Watch Theratechnologies Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Theratechnologies Inc. stocks are traded under the ticker THTX.
THTX stock has risen by 7.06% compared to the previous week, the month change is a 69.04% rise, over the last year Theratechnologies Inc. has showed a 95.65% increase.
We've gathered analysts' opinions on Theratechnologies Inc. future price: according to them, THTX price has a max estimate of 4.00 USD and a min estimate of 3.80 USD. Watch THTX chart and read a more detailed Theratechnologies Inc. stock forecast: see what analysts think of Theratechnologies Inc. and suggest that you do with its stocks.
THTX reached its all-time high on Nov 6, 2007 with the price of 51.89 USD, and its all-time low was 0.73 USD and was reached on Sep 25, 2013. View more price dynamics on THTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
THTX stock is 7.52% volatile and has beta coefficient of 0.95. Track Theratechnologies Inc. stock price on the chart and check out the list of the most volatile stocks — is Theratechnologies Inc. there?
Today Theratechnologies Inc. has the market capitalization of 66.24 M, it has increased by 29.03% over the last week.
Yes, you can track Theratechnologies Inc. financials in yearly and quarterly reports right on TradingView.
Theratechnologies Inc. is going to release the next earnings report on Jul 10, 2025. Keep track of upcoming events with our Earnings Calendar.
Theratechnologies Inc. revenue for the last quarter amounts to 19.05 M USD, despite the estimated figure of 20.41 M USD. In the next quarter, revenue is expected to reach 17.46 M USD.
THTX net income for the last quarter is 115.69 K USD, while the quarter before that showed −7.76 M USD of net income which accounts for 101.49% change. Track more Theratechnologies Inc. financial stats to get the full picture.
No, THTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has 105 employees. See our rating of the largest employees — is Theratechnologies Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Theratechnologies Inc. EBITDA is 14.26 M USD, and current EBITDA margin is 12.86%. See more stats in Theratechnologies Inc. financial statements.
Like other stocks, THTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Theratechnologies Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Theratechnologies Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Theratechnologies Inc. stock shows the neutral signal. See more of Theratechnologies Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.